Here are relevant reports on : brain-tumor-imaging-market
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
The global multimodal imaging market, valued at US$3.9 billion in 2022, stood at US$4.2 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.5 billion by the end of the period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Deep Brain Stimulation Market by Indication, Product Type, End User & Region - Global Forecast to 2030
The Deep Brain Stimulation (DBS) industry has experienced rapid expansion in recent years and is anticipated to do so in the years to come. An outline of the market forecast is given below:
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Brain Implants Market - Global Forecast to 2024
Brain implants (also referred as neuroprosthetics or neural implants) are technological devices that attach directly to a biological subject’s brain – generally placed on the surface of the brain or attached to the brain’s cortex. Growing ageing population and subsequent rise in incidences of neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and essential tremors, increasing health awareness, and technological innovations are some of the key factors driving the growth of the market. According to the WHO, an estimated 2.4 million people are diagnosed with epilepsy each year worldwide. Moreover, according to European Brain Council, globally, it is estimated that 6.3 million people affected with Parkinson’s disease in 2016. However, the high cost of brain implant devices and procedures may limit the brain implants market up to some extent.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Functional/Brain MRI System Market by Component (Magnet, RF Coil, Cooling System, Shim System), Field Strength (1.5T, 3T, 7T), Application (Brain Tumor, Presurgical Planning, Rehab, Epilepsy), Installed Base & Replacement Rate - Global Forecast to 2031
The global Functional/Brain MRI System market, valued at USD 0.79 billion in 2025, stood at USD 0.85 billion in 2026 and is projected to advance at a resilient CAGR of 8.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.25 billion by the end of the period. This growth is primarily fueled by the rising demand for high-resolution imaging to study brain activity, particularly in relation to neurological and psychiatric conditions such as stroke, brain tumors, epilepsy, Alzheimer's disease, and other neurological disorders.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Imaging Market by Product (CT, MRI, Imaging Systems, Imaging Reagents, Imaging Software, Accessories), Animal Type (Small, Large), Application (Oncology, Dentistry), Modality (Portable, Stationary), End User, Region - Global Forecast to 2031
The global veterinary imaging market, valued at US$2.13 billion in 2025, stood at US$2.29 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$3.33 billion by the end of the period. This growth is driven by several factors, including an increase in pet ownership, rising spending on animal healthcare, a growing demand for early and accurate diagnosis, and advancements in imaging technologies such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Noninvasive Cancer Diagnostics Market by Instruments (Solid Tumor, Blood Cancer, Lung Cancer, Breast Cancer), Technology (Clinical Chemistry, Immunochemistry, Molecular Diagnostics) - Analysis & Global Forecast to 2019
The global non-invasive cancer diagnostic market is expected to show considerable growth during the forecast period. This is attributed to growing cancer cases worldwide, especially breast and lung cancer. In 2013, in the U.S. there were more than 1,660,290 new cases of all type of cancers diagnosed in 2013 (American Cancer Society). Increased healthcare expenditure and increase research and development activities are some of the other factors driving the growth of this market. However factors such as high cost of treatment, and stringent regulatory guidelines are limiting the market growth.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis
The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Patient Derived Xenografts/PDX Models Market by Type (Mouse, Rat), Service (Model Creation, Characterization), Implantation Method (Subcutaneous), Tumor Type (Respiratory, GI, Gynecological), Application (Preclinical, Biomarker) - Global Forecast to 2030
The global patient derived xenografts/PDX models market, valued at US$0.32 billion in 2024, stood at US$0.37 billion in 2025 and is projected to advance at a resilient CAGR of 12.5% from 2025 to 2030, culminating in a forecasted valuation of US$0.66 billion by the end of the period. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, HIFU), Product (Systems, Consumables), Application (Liver, Lung, Kidney, Bone Cancer), Procedure (Surgical, Laparoscopic, Percutaneous), and End User - Global Forecast to 2031
The global tumor ablation market is projected to reach USD 1.89 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Urology Laser Market by Product (Holmium Laser, Thulium Laser, Neodymium, Green Laser Light, Diode Laser, Erbium), Applications (Benign Prostatic Hyperplasia [BPH], Kidney Stones, Tumor, Strictures) - Analysis and Global Forecasts to 2020
The urology laser is a rapidly growing field that has witnessed a number of technological advancements since its inception. Various products are now available in the market which is most commonly used in the surgical management of benign prostatic hyperplasia and as intracorporeal lithotripters. Additionally, the urology laser also finds it application in ablation of various urologic tumors and incising strictures of the upper- and lower urinary tract.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
